Searle has launched a generic version of semaglutide in a tablet form in Pakistan, a country with one of the highest prevalence of diabetes globally https://t.co/vvH3aRYsbX ...

This is the most effective treatment that's ever been shown in treating the leading cause of death and disability, which is high blood pressure. It also reduces insulin resistance. It can enhance cognitive capacities, and you also see it affecting things like depression and anxiety.It's called fasting. And there's more. Fasting introduces not just a chance to lose weight.It also mobilizes visceral fat which is the fat around the belly and the organs which is giving off inflammatory products that's causing h ...

Cmon manNew York Post (@nypost):The size of your neck can predict your risk of heart disease and diabetes — how many inches is too big https://t.co/pkZdeTtvnM https://t.co/xe3Cyg8nQm ...

Hi. Okay, I can't see anything. That's good.Uh is generally very difficult for me, but I'll try as much as I can. Okay, so um what do I do. I do health.Okay, health is my thing. Okay. So the topic today is how I absolutely love the topic and how all the speakers you've come here.There's a lot of pressure to be able to stand here but almost all the speakers who came here they had entirely different areas that they spoke about but all of it came down to the butterfly butterfly effect or the ripple effect and ...

It's not too late to invest in this company. Eli Lilly (LLY 0.73%) has been a terrific investment in recent years. Thanks to significant clinical progress and outstanding financial results, the company has become the largest healthcare player in the world: Eli Lilly's market cap was about $684 billion as of close of trading Aug. 1. That's some distance away from the $1 trillion mark. However, the drugmaker could become a $2 trillion stock within seven years. Here's why Eli Lilly could pull it off. Lilly cou ...

Clinical Trial Results & Drug Performance - Eli Lilly's diabetes drug, Mjaro, met the goal of a phase three trial by cutting the risk of heart disease in people with type 2 diabetes [1] - The trial showed Mjaro delivered an 8% lower rate of cardiovascular events than Trulicity and a 16% reduction in death from any cause [2] - Data strengthens the case for insurers, particularly in other parts of the world where the drug is launching [3] - One doctor worries the results aren't good enough to convince insurers in the US and might limit coverage of Mjaro since it wasn't significantly better than Trulicity [4] - Analysts were looking for a greater than 10% reduction in cardiovascular events [5] Market & Investor Reaction - The stock experienced a decline of approximately 4% [4] - There was disappointment as the drug didn't show it was significantly better than Trulicity [5][6] Emerging Trends - Plastic surgeons' business is booming due to "Ozempic face" (loose skin from weight loss) [7]

Lilly’s blockbuster diabetes drug Mounjaro was about as good at preventing heart attacks and strokes as its older medicine Trulicity in a head-to-head study https://t.co/53L2jWfyhk ...

A new kind of prescription is being written at Yale School of Medicine, but instead of pills or shots. These include skills like chopping and sautéing. They've had doctors and dietitians tell them that they need to change their diet, but didn't know how to do that.And so immediately, I think the response from patients was excitement about getting into the kitchen. >> Here, patients aren't just learning how to cook, they're learning how to take control of their health. Dr.. Nate Wood is a primary care physic ...

[Música] [Música] Hace unos 20 años acompañé a mi madre a una cita médica. Ella sufría de diabetes e hipertensión. Llegamos a una clínica y pues la experiencia fue desastrosa.Desde que llegamos a la portería, la persona que estaba ahí ni siquiera se interesó por nosotros. Luego fuimos a la recepción y la persona que estaba ahí solo le interesaba escribir el número de identificación de mi madre y nunca nos volteó a mirar. Luego pasamos al médico y el médico lo mismo, solo tomaba información en la computadora ...

Risk Assessment - GLP-1 drugs for diabetes may double the risk of serious eye disease in older patients [1]